Article info
PDFOriginal research
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients
- Correspondence to Lieke Lanjouw, Department of Epidemiology, University Medical Centre Groningen, Groningen, Groningen, Netherlands; l.lanjouw{at}umcg.nl
Citation
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients
Publication history
- Received January 18, 2023
- Accepted April 7, 2023
- First published May 3, 2023.
Article Versions
- You are currently viewing a Previous version of this article (7 August 2023).
- View the most recent version of this article
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.